An Empirical Taxonomy of Hospital Governing Board Roles

  • Abstract
  • Literature Map
  • Similar Papers
Abstract
Translate article icon Translate Article Star icon

To develop a taxonomy of governing board roles in U.S. hospitals. 2005 AHA Hospital Governance Survey, 2004 AHA Annual Survey of Hospitals, and Area Resource File. A governing board taxonomy was developed using cluster analysis. Results were validated and reviewed by industry experts. Differences in hospital and environmental characteristics across clusters were examined. One-thousand three-hundred thirty-four hospitals with complete information on the study variables were included in the analysis. Five distinct clusters of hospital governing boards were identified. Statistical tests showed that the five clusters had high internal reliability and high internal validity. Statistically significant differences in hospital and environmental conditions were found among clusters. The developed taxonomy provides policy makers, health care executives, and researchers a useful way to describe and understand hospital governing board roles. The taxonomy may also facilitate valid and systematic assessment of governance performance. Further, the taxonomy could be used as a framework for governing boards themselves to identify areas for improvement and direction for change.

Similar Papers
  • Research Article
  • 10.22219/jaa.v7i4.34208
Can boards of directors in large companies effectively prevent fraud?
  • Nov 30, 2024
  • Jurnal Akademi Akuntansi
  • Meiliana + 2 more

Purpose: The aim to test the impact of the characteristics of board of directors in reducing and preventing the possibility of financial statement fraud with firm size as variable moderating. Methodoly/Approach: The technique used purposive sampling method resulting of total 435 data and 87 companies in mining sector for the period 2018 – 2022. Findings: The result of this study is that firm size do not strengthen the board independence, board remuneration, board financial and industry expertise, and number meeting board of director on fraudulent financial statement. However, firm size strengthens the CEO financial and industry expertise on fraudulent financial statement. Another result is CEO financial and industry expertise, board financial expertise has a negative influence on fraudulent financial statement, but board independence, board remuneration, board industry expertise and board effort do not have influence on fraudulent financial statement. Practical and Theoretical contribution/Originality: This research is expected to be helpful to the companies regarding the importance of the characteristics of the board of directors whether in large and small companies to prevent and detect fraudulent financial statements. Research Limitation: This limitation is focused only on mining sector companies, and it only measures the characteristic board of directors’ variables.

  • Research Article
  • Cite Count Icon 6
  • 10.1016/s2155-8256(17)30127-8
Analysis and Priorities: Developing a Modern, Effective, Regulatory Framework
  • Jul 1, 2017
  • Journal of Nursing Regulation
  • David Benton

Analysis and Priorities: Developing a Modern, Effective, Regulatory Framework

  • Abstract
  • Cite Count Icon 1
  • 10.1182/blood.v128.22.103.103
Diffuse Large B-Cell Lymphoma with Primary Treatment Failure: Identification of Ultra-High Risk Patients and Benchmarking for Experimental Therapies
  • Dec 2, 2016
  • Blood
  • Kami J Maddocks + 27 more

Diffuse Large B-Cell Lymphoma with Primary Treatment Failure: Identification of Ultra-High Risk Patients and Benchmarking for Experimental Therapies

  • Abstract
  • Cite Count Icon 4
  • 10.1182/blood-2018-99-116604
Absence of Contribution to a Differential Outcome of the Stringent Complete Response IMWG Category Respect to the Conventional CR in Multiple Myeloma. a Validation Analysis Based on the Pethema/GEM2012MENOS65 Phase III Clinical Trial
  • Nov 29, 2018
  • Blood
  • Ana Jiménez Ubieto + 24 more

Absence of Contribution to a Differential Outcome of the Stringent Complete Response IMWG Category Respect to the Conventional CR in Multiple Myeloma. a Validation Analysis Based on the Pethema/GEM2012MENOS65 Phase III Clinical Trial

  • Abstract
  • 10.1182/blood-2019-131003
Prognostic Significance of Bone Marrow Cellularity in the Outcome of Patients with Myelodysplastic Syndromes Treated with Azacyitidine: A Retrospective Analysis from the Hellenic MDS Study Group
  • Nov 13, 2019
  • Blood
  • Elena E Solomou + 17 more

Prognostic Significance of Bone Marrow Cellularity in the Outcome of Patients with Myelodysplastic Syndromes Treated with Azacyitidine: A Retrospective Analysis from the Hellenic MDS Study Group

  • Abstract
  • Cite Count Icon 2
  • 10.1182/blood-2019-124730
Adherence to Treatment in Myelofibrosis Patients: Preliminary Results from Italian Romei Observational Study
  • Nov 13, 2019
  • Blood
  • Paola Guglielmelli + 13 more

Adherence to Treatment in Myelofibrosis Patients: Preliminary Results from Italian Romei Observational Study

  • Abstract
  • 10.1182/blood-2019-125330
Characteristics and Outcomes of Therapy-Related Versus De Novo Acute Myeloid Leukemia with Normal Karyotype
  • Nov 13, 2019
  • Blood
  • Bachar Samra + 16 more

Characteristics and Outcomes of Therapy-Related Versus De Novo Acute Myeloid Leukemia with Normal Karyotype

  • Abstract
  • 10.1182/blood-2019-122400
Patient-Specific Risk Factors Independently Influence Survival in Myelodysplastic Syndromes in an Unbiased Review of EHR Records
  • Nov 13, 2019
  • Blood
  • Travis Spaulding + 9 more

Patient-Specific Risk Factors Independently Influence Survival in Myelodysplastic Syndromes in an Unbiased Review of EHR Records

  • Abstract
  • Cite Count Icon 3
  • 10.1182/blood-2018-99-115958
Molecular Subtypes of Splenic Marginal Zone Lymphoma (SMZL) Are Associated with Distinct Pathogenic Mechanisms and Outcomes - Interim Analysis of the IELSG46 Study
  • Nov 29, 2018
  • Blood
  • Francesca Guidetti + 63 more

Molecular Subtypes of Splenic Marginal Zone Lymphoma (SMZL) Are Associated with Distinct Pathogenic Mechanisms and Outcomes - Interim Analysis of the IELSG46 Study

  • Abstract
  • Cite Count Icon 2
  • 10.1182/blood-2020-136983
Practice Patterns and Real-Life Outcomes for Patients with Acute Promyelocytic Leukemia
  • Nov 5, 2020
  • Blood
  • Jan Philipp Bewersdorf + 10 more

Practice Patterns and Real-Life Outcomes for Patients with Acute Promyelocytic Leukemia

  • Research Article
  • 10.5897/ajbm11.2632
The study of the relationship between firms' board of directors' structure and criteria in assessing the firm performance
  • Feb 22, 2012
  • AFRICAN JOURNAL OF BUSINESS MANAGEMENT
  • Younes Badavar Nahandi + 3 more

The main purpose in this article is to study the relationship between firms' board of directors’ structure and accounting and economic criteria in assessing the performance of companies listed at Tehran Stock Exchange. To do this, 94 firms from our statistical society were chosen. We had access to the needed information for a period of six years (2004 to 2009) about those firms. Some criteria were chosen as dependent variables as follows: return on investment, stock return yearly and P/B ratio for financial performance assessment criteria and Tobins’Q, market value-added and economical value-added for economic performance assessment criteria have been considered. Then, the data related to independent variables, in which two criteria of firms' board of directors’ structure as ratio of independent members of board of directors and financial specialty of members of board of directors were studied. The research results indicate that there is a positive and meaningful relationship between ratio of independent members of board of directors and financial specialty of members of board of directors with financial and economic criteria in assessing the firm performance. Key words: Corporate governance, board of directors’ structure, financial criteria, economical criteria.

  • Research Article
  • Cite Count Icon 7
  • 10.1097/hmr.0000000000000165
Trends in governance structure and activities among not-for-profit U.S. hospitals: 2009-2015.
  • Jul 1, 2019
  • Health Care Management Review
  • Olena Mazurenko + 2 more

In U.S. hospitals, boards of directors (BODs) have numerous governance responsibilities including overseeing hospital activities and guiding strategic decisions. BODs can help hospitals adapt to changes in their markets including those stemming from a shift from fee-for-service to value-based purchasing. The recent increase in market turbulence for hospitals has brought renewed attention to the work of BODs. The aim of the study was to examine trends in hospital BOD structure and activities and determine whether these changes are commensurate with approaches designed to respond to market pressures. We examined hospital level data from The Governance Institute Survey (2009, 2011, 2013, and 2015) and corresponding years of the American Hospital Association Annual Survey in a pooled, cross-sectional design. We conducted individual multivariate models with adjustments for hospital and market characteristics, comparing the changes in BOD structures, demographics, and activities over time. The sample included 1,811 hospital-year observations, including 682 unique facilities. We found that BODs in 2015 had less internal management (β = -2.25, p < .001) and fewer employed and nonemployed physicians (β = -8.28, p < .001) involved on the BOD. Moreover, compared to 2009, racial and ethnic minorities (2013 β = 2.88, p < .001) and women (2013 β = 1.60, p = .045; 2015 β = 2.06, p = .049) on BODs increased over time. In addition, BODs were significantly less likely to spend time on the following activities in 2015, as compared to 2009: discussing strategy and setting policy (β = -5.46, p = .002); receiving reports from management, board committees, and subsidiaries (β = -29.04, p < .001); and educating board members (β = -4.21, p < .001). Finally, BODs had no changes in the type of committees reported over time. Our results indicate that hospital BODs deploy various strategies to adapt to current market trends. Hospital decision-makers should be aware of the potential effects of board structure on organization's position in the changing health care market.

  • Research Article
  • Cite Count Icon 8
  • 10.2308/ciia-19-026
Attributes Influencing Clients' Auditor Choices: The Expectation Gaps between Auditors and Board Members
  • Mar 27, 2020
  • Current Issues in Auditing
  • Francis Goddard + 1 more

SUMMARY This paper reports the results of a survey of board members who participate in auditor appointments and audit firm partners and (senior) managers on attributes influencing clients' auditor choice decisions. We identify several “expectation gaps” between the importance that board members assign to attributes and the importance that auditors expect board members to assign to the same attributes. The results indicate that board members deem low audit fees, as well as a good relationship with the audit partner, to be less important than audit partners and managers expect. We find the opposite for attributes related to audit quality, such as technical competence and industry expertise, as well as professional skepticism and independence of mind, and business know-how of the audit firm, which board members assess as more important than audit partners and managers expect. The findings have important implications for auditors in audit tenders.

  • Abstract
  • Cite Count Icon 13
  • 10.1182/blood-2021-145764
Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy
  • Nov 5, 2021
  • Blood
  • Brian T Hill + 46 more

Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy

  • Abstract
  • Cite Count Icon 2
  • 10.1182/blood-2021-153560
Long-Term Survival Benefit of Eculizumab Treatment in Patients with Paroxysmal Nocturnal Hemoglobinuria: Data from the International PNH Registry
  • Nov 5, 2021
  • Blood
  • Louis Terriou + 6 more

Long-Term Survival Benefit of Eculizumab Treatment in Patients with Paroxysmal Nocturnal Hemoglobinuria: Data from the International PNH Registry

Save Icon
Up Arrow
Open/Close
Notes

Save Important notes in documents

Highlight text to save as a note, or write notes directly

You can also access these Documents in Paperpal, our AI writing tool

Powered by our AI Writing Assistant